Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Residual Neuromuscular Blockade in Cardiac Surgery Patients

NCT03574337 is registered in ClinicalTrials.gov with Henry Ford Health System as lead sponsor.

NCT NCT03574337
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03574337 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Residual Neuromuscular Blockade in Cardiac Surgery Patients
Lead sponsor
Henry Ford Health System
Phase
Phase 4
Overall status
Withdrawn
Start date
August 1, 2018
Completion date
August 30, 2018
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

residual neuromuscular blockade